Articles written by: Marguerite Chambers

London: Anglo American PLC (LON:AAL) Stock Has Just Had Its Hold Rating Reiterated by Deutsche Bank. Shares now Have a GBX 2000.00 Target

London: Anglo American PLC (LON:AAL) Stock Has Just Had Its Hold Rating Reiterated by Deutsche Bank. Shares now Have a GBX 2000.00 Target

Investors sentiment decreased to 0.88 in 2018 Q3. Its down 0.07, from 0.95 in 2018Q2. It turned negative, as 61 investors sold Anglo American plc shares while 154 reduced holdings. 66 funds opened positions while 124 raised stakes. 362.38 million shares or 1.18% less from 366.72 million shares in 2018Q2 […]

Yirendai Ltd. (YRD) Analysts See $0.51 EPS

Analysts expect Yirendai Ltd. (NYSE:YRD) to report $0.51 EPS on March, 13.They anticipate $0.60 EPS change or 54.05 % from last quarter’s $1.11 EPS. YRD’s profit would be $30.96M giving it 6.88 P/E if the $0.51 EPS is correct. After having $0.35 EPS previously, Yirendai Ltd.’s analysts see 45.71 % […]

Is OneMain Holdings Inc (OMF) a Sell? What does BTIG Think?

Is OneMain Holdings Inc (OMF) a Sell? What does BTIG Think?

Why Has BTIG Given OneMain Holdings Inc (OMF) a $43 Price Target In a report sent to investors and clients on 21 February, stock analysts at BTIG has initiated coverage for OneMain Holdings Inc (OMF) shares. The firm has decided to set a “Buy” rating along with a $43, adding […]

EPS for Benefitfocus, Inc. (BNFT) Expected At $-0.04

EPS for Benefitfocus, Inc. (BNFT) Expected At $-0.04

Investors sentiment decreased to 1.51 in Q3 2018. Its down 2.20, from 3.71 in 2018Q2. It turned negative, as 13 investors sold Benefitfocus, Inc. shares while 22 reduced holdings. 20 funds opened positions while 33 raised stakes. 29.30 million shares or 49.17% less from 57.65 million shares in 2018Q2 were […]

$-0.08 EPS Expected for Team, Inc. (TISI)

$-0.08 EPS Expected for Team, Inc. (TISI)

Investors sentiment decreased to 0.98 in 2018 Q3. Its down 0.14, from 1.12 in 2018Q2. It dropped, as 15 investors sold Team, Inc. shares while 47 reduced holdings. 17 funds opened positions while 44 raised stakes. 33.84 million shares or 3.48% less from 35.06 million shares in 2018Q2 were reported. […]

Analysts See $-0.14 EPS for Aevi Genomic Medicine, Inc. (GNMX)

Analysts expect Aevi Genomic Medicine, Inc. (NASDAQ:GNMX) to report $-0.14 EPS on March, 12.They anticipate $0.01 EPS change or 7.69 % from last quarter’s $-0.13 EPS. After having $-0.12 EPS previously, Aevi Genomic Medicine, Inc.’s analysts see 16.67 % EPS growth. The stock decreased 2.93% or $0.0062 during the last […]

Axonics Modulation Technologies, Inc. (AXNX) Analysts See $-0.37 EPS

Analysts expect Axonics Modulation Technologies, Inc. (NASDAQ:AXNX) to report $-0.37 EPS on March, 12.After having $-2.67 EPS previously, Axonics Modulation Technologies, Inc.’s analysts see -86.14 % EPS growth. The stock decreased 4.44% or $1 during the last trading session, reaching $21.5. About 152,121 shares traded or 29.65% up from the […]

Analysts See $0.91 EPS for Cargojet Inc. (CJT)

Analysts See $0.91 EPS for Cargojet Inc. (CJT)

Analysts expect Cargojet Inc. (TSE:CJT) to report $0.91 EPS on March, 11.They anticipate $0.10 EPS change or 12.35 % from last quarter’s $0.81 EPS. T_CJT’s profit would be $12.23M giving it 22.93 P/E if the $0.91 EPS is correct. After having $0.35 EPS previously, Cargojet Inc.’s analysts see 160.00 % […]

EPS for Krystal Biotech, Inc. (KRYS) Expected At $-0.24

Analysts expect Krystal Biotech, Inc. (NASDAQ:KRYS) to report $-0.24 EPS on March, 11.After having $-0.26 EPS previously, Krystal Biotech, Inc.’s analysts see -7.69 % EPS growth. The stock increased 1.07% or $0.24 during the last trading session, reaching $22.57. About 60,791 shares traded or 33.53% up from the average. Krystal […]

Eiger BioPharmaceuticals, Inc. (EIGR) Analysts See $-0.81 EPS

Eiger BioPharmaceuticals, Inc. (EIGR) Analysts See $-0.81 EPS

Analysts expect Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) to report $-0.81 EPS on March, 11.They anticipate $0.30 EPS change or 27.03 % from last quarter’s $-1.11 EPS. After having $-1.20 EPS previously, Eiger BioPharmaceuticals, Inc.’s analysts see -32.50 % EPS growth. The stock decreased 3.94% or $0.54 during the last trading session, […]